Van ECK Associates Corp Decreases Position in Stericycle, Inc. (NASDAQ:SRCL)

Van ECK Associates Corp lowered its holdings in Stericycle, Inc. (NASDAQ:SRCL) by 6.1% in the fourth quarter, according to its most recent Form 13F filing with the SEC. The fund owned 83,988 shares of the business services provider’s stock after selling 5,410 shares during the period. Van ECK Associates Corp owned about 0.09% of Stericycle worth $4,162,000 at the end of the most recent reporting period.

Other institutional investors and hedge funds have also recently bought and sold shares of the company. Ramirez Asset Management Inc. purchased a new position in Stericycle in the third quarter valued at about $45,000. Exchange Traded Concepts LLC boosted its holdings in Stericycle by 87.5% in the third quarter. Exchange Traded Concepts LLC now owns 1,001 shares of the business services provider’s stock valued at $45,000 after purchasing an additional 467 shares during the last quarter. Essex Investment Management Co. LLC boosted its holdings in Stericycle by 16.8% in the third quarter. Essex Investment Management Co. LLC now owns 2,691 shares of the business services provider’s stock valued at $120,000 after purchasing an additional 387 shares during the last quarter. Blue Trust Inc. boosted its holdings in Stericycle by 15.4% in the fourth quarter. Blue Trust Inc. now owns 3,125 shares of the business services provider’s stock valued at $155,000 after purchasing an additional 416 shares during the last quarter. Finally, Pathstone Family Office LLC purchased a new position in Stericycle in the third quarter valued at about $230,000. Hedge funds and other institutional investors own 98.82% of the company’s stock.

Wall Street Analyst Weigh In

A number of research analysts recently commented on SRCL shares. Truist Financial reduced their price target on Stericycle from $57.00 to $50.00 and set a “hold” rating for the company in a report on Monday, April 29th. Royal Bank of Canada restated an “outperform” rating and set a $69.00 price objective on shares of Stericycle in a research note on Thursday, March 7th. Stifel Nicolaus upped their price objective on Stericycle from $70.00 to $75.00 and gave the company a “buy” rating in a research note on Thursday, February 29th. Robert W. Baird cut their price objective on Stericycle from $62.00 to $55.00 and set a “neutral” rating on the stock in a research note on Friday, April 26th. Finally, StockNews.com cut Stericycle from a “buy” rating to a “hold” rating in a research note on Tuesday, April 2nd. One research analyst has rated the stock with a sell rating, three have issued a hold rating and two have issued a buy rating to the company’s stock. According to MarketBeat, the stock presently has an average rating of “Hold” and a consensus target price of $59.40.

Stericycle Stock Up 3.1 %

Shares of Stericycle stock opened at $46.18 on Monday. The company has a current ratio of 1.11, a quick ratio of 1.11 and a debt-to-equity ratio of 0.55. The business’s 50 day simple moving average is $50.91 and its 200-day simple moving average is $48.28. The stock has a market capitalization of $4.29 billion, a price-to-earnings ratio of -209.91, a PEG ratio of 2.49 and a beta of 1.12. Stericycle, Inc. has a twelve month low of $37.78 and a twelve month high of $57.06.

Stericycle (NASDAQ:SRCL) last announced its quarterly earnings results on Thursday, April 25th. The business services provider reported $0.57 earnings per share for the quarter, topping analysts’ consensus estimates of $0.54 by $0.03. Stericycle had a positive return on equity of 7.31% and a negative net margin of 0.74%. The business had revenue of $664.90 million for the quarter, compared to analysts’ expectations of $676.42 million. During the same period in the prior year, the firm earned $0.49 EPS. The business’s quarterly revenue was down 2.8% on a year-over-year basis. Equities research analysts forecast that Stericycle, Inc. will post 2.32 earnings per share for the current year.

About Stericycle

Stericycle, Inc, together with its subsidiaries, provides regulated waste and compliance services in the United States, Europe, and internationally. The company offers regulated waste and compliance services, including regulated medical waste, sharps waste management and disposal, pharmaceutical waste management and disposal, chemotherapy waste and disposal, controlled substance waste disposal, healthcare hazardous waste, and integrated waste stream solutions; specialty services, such as MedDrop medication collection kiosks, safe community solutions, SafeDrop sharps mailback solutions, and airport and maritime waste services; medical supply store services, that includes sharps and disposable biohazardous waste containers, infection control supplies, and seal&send medication mail back; and compliance solutions including Steri-Safe compliance solutions.